Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BTOG 2020 | ADSCaN trial: testing accelerated radiotherapy in NSCLC

Matthew Hatton, MSc, MBChB, MRCP, FRCP, FRCR, University of Sheffield, Sheffield, UK, discusses the aims of the ADSCaN trial (ISRCTN47674500) testing accelerated, dose-escalated, chemo-radiotherapy in NSCLC. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK.